Treace Medical Concepts (TMCI) Profit After Tax (2020 - 2026)
Treace Medical Concepts (TMCI) posted Profit After Tax of -$18.1 million for Q1 2026, down 92.24% on a QoQ basis from -$9.4 million in Q4 2025, and down 13.42% year-over-year from -$20.9 million in Q1 2025.
Treace Medical Concepts (TMCI) Profit After Tax (2020 - 2026) Analysis & Trends
Treace Medical Concepts' Profit After Tax history runs 7 years deep, the most recent figure standing at -$18.1 million for Q1 2026.
- Quarterly Profit After Tax fell 13.42% year-over-year to -$18.1 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$61.1 million (down 15.71% YoY) and the FY2025 annual result came in at -$59.0 million, down 5.72% from the prior year.
- Profit After Tax was -$18.1 million for Q1 2026 at Treace Medical Concepts, down from -$9.4 million in the prior quarter.
- Across five years, Profit After Tax topped out at -$567000.0 in Q4 2024 and bottomed at -$21.2 million in Q2 2024.
- A 5-year average of -$13.2 million and a median of -$15.1 million in 2024 frame the typical range for Profit After Tax.
- Annual changes were most pronounced in 2024 — Profit After Tax surged 90.5% — and 2025, when it slumped 1556.79%.
- Treace Medical Concepts' Profit After Tax stood at -$4.4 million in 2022, then plunged by 35.31% to -$6.0 million in 2023, then jumped by 90.5% to -$567000.0 in 2024, then slumped by 1556.79% to -$9.4 million in 2025, then tumbled by 92.24% to -$18.1 million in 2026.
- Business Quant data shows TMCI's Profit After Tax at -$18.1 million in Q1 2026, -$9.4 million in Q4 2025, and -$16.3 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | PAT (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | 1.08 Bn |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | 745.00 Mn |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | 1.26 Bn |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | 1.34 Bn |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | 380.70 Mn |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | 199.50 Mn |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | 170.93 Mn |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | 411.00 Mn |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | - |
| 10 | Treace Medical Concepts | 261.60 Mn | 209.75 Mn | 37.41 Mn | -18.06 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -18.06 Mn |
| Dec 31, 2025 | -9.39 Mn |
| Sep 30, 2025 | -16.29 Mn |
| Jun 30, 2025 | -17.40 Mn |
| Mar 31, 2025 | -15.92 Mn |
| Dec 31, 2024 | -567,000.00 |
| Sep 30, 2024 | -15.14 Mn |
| Jun 30, 2024 | -21.21 Mn |
| Mar 31, 2024 | -18.68 Mn |
| Dec 31, 2023 | -5.97 Mn |
| Sep 30, 2023 | -17.52 Mn |
| Jun 30, 2023 | -12.27 Mn |
| Mar 31, 2023 | -13.45 Mn |
| Dec 31, 2022 | -4.41 Mn |
| Sep 30, 2022 | -12.13 Mn |
| Jun 30, 2022 | -17.23 Mn |
| Mar 31, 2022 | -9.04 Mn |
| Dec 31, 2021 | -6.62 Mn |
| Sep 30, 2021 | -6.42 Mn |
| Jun 30, 2021 | -5.08 Mn |